Sublingual immunotherapy improves symptoms of allergical rhinoconjunctivitis and asthma

Evidence-Based Medicine

Volumn 19, Issue 1, 2014, Pages 34-35

  Gentile, Deborah A ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGICAL RHINOCONJUNCTIVITIS; ASTHMA; CONJUNCTIVITIS; HUMAN; NOTE; QUALITY OF LIFE; RHINITIS; RHINOCONJUNCTIVITIS; SUBLINGUAL IMMUNOTHERAPY;

ASTHMA; CONJUNCTIVITIS, ALLERGIC; DESENSITIZATION, IMMUNOLOGIC; HUMANS; RHINITIS, ALLERGIC, PERENNIAL;

EID: 84895558881     PISSN: 13565524     EISSN: 14736810     Source Type: Journal    
DOI: 10.1136/eb-2013-101371     Document Type: Note

References (4)

1. Canonica GW, Bousquet J, Casale T, et al. Sublingual immunotherapy: World Health Organization Position Paper 2009. Allergy 2009;64: 1-59.
2. Cox L, Jacobsen L. Comparison of allergen immunotherapy practice patterns in the United States and Europe. Ann Allergy Asthma Immunol 2009;103: 451-9.
3. Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systemic review and meta-analysis. Allergy 2005;60: 4-12.
4. Radulvic S, Calderon MA, Wilson D, et al. Sublingual immunotherapy for allergic rhinitis. Chochrane Databae Syst Rev 2010;(12):CD002893.